Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/29/17 → 03/18/20 |
Funding
- AbbVie Incorporated: $12,614.35
A Phase 1 Dose Escalation and Phase 2 Randomized, Placebo-Controlled Study of the Efficacy and Tolerability of Veliparib in Combination with Paclitaxel/Carboplatin-Based Chemoradiotherapy
- Keresztes, Roger (PI)
- Grossman, Craig (CoPI)
Project: Research